XT
DARE icon

XTX Topco’s Dare Bioscience DARE Stock Holding History

XTX Topco’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.7K Buy
22,339
+11,356
+103% +$19.4K ﹤0.01% 3376
2025
Q4 		$21.2K Buy
+10,983
New +$21.9K ﹤0.01% 3049
2024
Q2 		– Sell
-2,341
Closed -$13.8K – 1984
2024
Q1 		$13.8K Buy
+2,341
New +$11.5K ﹤0.01% 1647
2022
Q3 		– Sell
-1,571
Closed -$23K – 1152
2022
Q2 		$23K Sell
1,571
-582
-27% -$8.76K 0.01% 803
2022
Q1 		$38K Buy
2,153
+429
+25% +$8.11K 0.02% 611
2021
Q4 		$41K Sell
1,724
-842
-33% -$17.3K 0.02% 583
2021
Q3 		$51K Buy
2,566
+1,391
+118% +$27.4K 0.02% 602
2021
Q2 		$27K Buy
+1,175
New +$20.1K 0.01% 755

Other funds holding DARE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

XTX Topco's DARE Position: Q1 2026 in Review

XTX Topco increased its Dare Bioscience (DARE) stake by 103% in Q1 2026, buying an estimated $19.4K and bringing the position to 22,339 shares worth $40.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3376.

XTX Topco first reported a position in DARE in Q2 2021 and has held it in 8 quarters since. The position peaked at $51K in Q3 2021. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

  • XTX Topco held 22,339 shares of Dare Bioscience worth $40.7K as of Q1 2026.
  • XTX Topco bought 11,356 Dare Bioscience shares in Q1 2026, an estimated $19.4K.
  • Dare Bioscience made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3376 holding.
  • XTX Topco first reported a position in Dare Bioscience in Q2 2021 and has held it in 8 quarters since.
  • XTX Topco's Dare Bioscience position peaked at $51K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.